Partner Headlines - MYGN

  1. PetSmart and Other Secular Growth Picks (ACT, MYGN, ...

    Benzinga

  2. UPDATE: JP Morgan Downgrades Underweight on Myriad ...

    Benzinga

  3. Amgen buys DeCode Genetics

    Investors Business Daily

  4. Amgen Buying DeCode Genetics To Find Targeted Drugs

    Investors Business Daily

  5. Stock Averages Back Off In Mixed Volume

    Investors Business Daily

  6. Stocks Worsen In Late Trade; Sturm Ruger Pares Losses

    Investors Business Daily

  7. Myriad Says US Supreme Court to Hear Isolated DNA Patent ...

    Benzinga

  8. Stocks Tack On More Gains; Cirrus Logic Retakes 200-Day Line

    Investors Business Daily

  9. Parexel International Leads Medical Research Group

    Investors Business Daily

  10. Leggett, Sherwin-Williams, DaVita Buck Weak Market

    Investors Business Daily

  11. Myriad Genetics Stock Hits High On Earnings Beat

    Investors Business Daily

  12. Stocks Improve In Late Trade; Nationstar Pares Losses

    Investors Business Daily

  13. UPDATE: Bank of America Upgrades Myriad Genetics to Buy ...

    Benzinga

  14. Myriad's HRD Score Detects Loss of DNA Repair Function ...

    Benzinga

  15. UPDATE: Piper Jaffray Upgrades Myriad Genetics to ...

    Benzinga

  16. Myriad Genetics Inc. (MYGN) CFO James S Evans sells ...

    GuruFocus

  17. Myriad Says Utah Medicare Will Add Prostate Test to Next ...

    Benzinga

  18. Rosetta Genomics (NASDAQ: ROSG), a developer and provider of

    Benzinga

  19. Health Care Sector Wrap

    FOXBusiness

  20. Health Care Sector Wrap

    FOXBusiness

  21. Court Allows Myriad To Patent Cancer Genes

    YCharts

  22. Myriad wins on patent appeal

    Investors Business Daily

  23. Myriad Genetics Patents Upheld, But Fight Not Over

    Investors Business Daily

  24. Health Care Sector Wrap

    FOXBusiness

  25. Myriad Genetics

    Investors Business Daily

  26. Myriad Genetics Reports In-Line Q4, But Costs To Rise

    Investors Business Daily

  27. Myriad Genetics Earnings Expected To Stay On Rebound

    Investors Business Daily

  28. Myriad Genetics and Pharma Mar Enter Into Companion ...

    Benzinga

  29. Top 4 Stocks In The Research Services Industry With The ...

    Benzinga

  30. Bio-Rad and Myriad RBM Partner to Commercialize ...

    Benzinga

  31. Myriad Genetics Inc. (MYGN) CFO James S Evans sells ...

    GuruFocus

  32. Myriad Genetics (MYGN) Up 2% after Goldman Upgrade

    At Market Intelligence Center

  33. UPDATE: Goldman Sachs Upgrades Myriad Genetics to Buy on ...

    Benzinga

  34. Myriad Genetics

    Investors Business Daily

  35. UPDATE: Bank of America Initiates Coverage on Myriad ...

    Benzinga

  36. Stocks Ease Off Session Highs

    Investors Business Daily

  37. Stocks Headed For Mildly Higher Start

    Investors Business Daily

  38. Myriad Genetics (MYGN) Gains 3.8% after Supreme Court ...

    At Market Intelligence Center

  39. Myriad Genetics Inc. (MYGN) CFO James S Evans sells ...

    at GuruFocus

  40. Myriad Genetics

    at IBD

  41. Will Roche's Takeover Bid Help People Predict Diseases?

    at Benzinga

  42. End-of-Day Market Summary for January 18, 2012

    at Benzinga

  43. Myriad Genetics Acquires Exclusive Rights to RAD51C Gene

    at Benzinga
Marketplace
Trading Center